HK1221260A1 - 擴增 細胞的方法 - Google Patents

擴增 細胞的方法

Info

Publication number
HK1221260A1
HK1221260A1 HK16109446.3A HK16109446A HK1221260A1 HK 1221260 A1 HK1221260 A1 HK 1221260A1 HK 16109446 A HK16109446 A HK 16109446A HK 1221260 A1 HK1221260 A1 HK 1221260A1
Authority
HK
Hong Kong
Prior art keywords
methods
expanding cells
expanding
cells
Prior art date
Application number
HK16109446.3A
Other languages
English (en)
Inventor
Stewart Abbot
Willard Foss
Thomas Daniel
Original Assignee
Anthrogenesis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anthrogenesis Corp filed Critical Anthrogenesis Corp
Publication of HK1221260A1 publication Critical patent/HK1221260A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0636—T lymphocytes
    • C12N5/0637—Immunosuppressive T lymphocytes, e.g. regulatory T cells or Treg
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2302—Interleukin-2 (IL-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/515—CD3, T-cell receptor complex
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/599—Cell markers; Cell surface determinants with CD designations not provided for elsewhere

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
HK16109446.3A 2013-06-24 2016-08-08 擴增 細胞的方法 HK1221260A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361838685P 2013-06-24 2013-06-24
PCT/US2014/043609 WO2014209855A1 (en) 2013-06-24 2014-06-23 Methods of expanding t cells

Publications (1)

Publication Number Publication Date
HK1221260A1 true HK1221260A1 (zh) 2017-05-26

Family

ID=52142587

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16109446.3A HK1221260A1 (zh) 2013-06-24 2016-08-08 擴增 細胞的方法

Country Status (7)

Country Link
US (2) US20160137980A1 (zh)
EP (2) EP3013942A4 (zh)
JP (3) JP2016523102A (zh)
AU (2) AU2014302771A1 (zh)
CA (1) CA2916865A1 (zh)
HK (1) HK1221260A1 (zh)
WO (1) WO2014209855A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016183350A1 (en) * 2015-05-13 2016-11-17 Terumobct, Inc. Cell expansion
JP6902018B2 (ja) * 2015-07-21 2021-07-14 シティ・オブ・ホープＣｉｔｙ ｏｆ Ｈｏｐｅ キメラ抗原受容体及び他の受容体の発現に対するｔ細胞
KR20200019231A (ko) * 2017-06-22 2020-02-21 보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 조절 면역 세포를 제조하기 위한 방법 및 이의 용도
US20230030773A1 (en) * 2019-12-16 2023-02-02 The Board Of Trustees Of The Leland Stanford Junior University Use of polyvinyl alcohol for cell culture of immune cells
KR20230166150A (ko) 2020-08-19 2023-12-06 젠코어 인코포레이티드 항-cd28 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6010902A (en) * 1988-04-04 2000-01-04 Bristol-Meyers Squibb Company Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
US5158880A (en) * 1988-09-23 1992-10-27 E. I. Du Pont De Nemours And Company Process for preparing solid perfluorocarbon polymer supports having attached perfluorocarbon-substituted ligand or binder
US6534055B1 (en) * 1988-11-23 2003-03-18 Genetics Institute, Inc. Methods for selectively stimulating proliferation of T cells
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
DE69433723T3 (de) 1993-02-22 2008-10-30 Abraxis Bioscience, Inc., Los Angeles Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen
WO1994029436A1 (en) * 1993-06-04 1994-12-22 The United States Of America Represented By The Secretary Of The Navy Methods for selectively stimulating proliferation of t cells
US6576236B1 (en) * 1994-07-01 2003-06-10 Dana Farber Cancer Institute Methods for stimulating T cell responses by manipulating a common cytokine receptor γ chain
JP2005517025A (ja) * 2002-02-08 2005-06-09 エクサイト セラピーズ， インコーポレイテッド 免疫学的欠損を有する患者において免疫応答性を回復するための、組成物および方法
WO2004003142A2 (en) * 2002-06-28 2004-01-08 Xcyte Therapies, Inc. Compositions and methods for restoring immune repertoire in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
EP1391504A1 (en) * 2002-08-12 2004-02-25 Gerold Schuler CD4+ CD25- T cells and Tr1-like regulatory T cells
TWI317291B (en) * 2005-01-12 2009-11-21 Tung Hai Biotechnology Corp Polyglutamic acid (gamma;-pga, h form), y-polyglutamates and gamma-polyglutamate hydrogels for use as super moisturizers in cosmetic and personal care products
US20080267972A1 (en) * 2005-02-10 2008-10-30 Invitrogen Corporation Donor Lymphocyte Infusion of T Cells For the Treatment of Cancer
US8728527B2 (en) * 2006-07-24 2014-05-20 Luminus Biosciences, Inc. Solid nanoparticle formulation of water insoluble pharmaceutical substances with reduced ostwald ripening
US7713688B2 (en) * 2007-01-26 2010-05-11 Bioe, Llc Methods and compositions for depleting specific cell populations from blood tissues
CA2770697A1 (en) * 2009-08-25 2011-03-03 Agnes Ostafin Method and apparatus for continuous removal of submicron sized particles in a closed loop liquid flow system
US20120321665A1 (en) * 2009-12-14 2012-12-20 Benaroya Research Institute At Virginia Mason Compositions and methods for treating airway inflammatory diseases
WO2011078990A1 (en) * 2009-12-14 2011-06-30 Benaroya Research Institute At Virginia Mason Hydrogels comprising hyaluronan and at least one t cell induction agent
US8709451B2 (en) * 2010-01-20 2014-04-29 University Of Utah Research Foundation Stable nanoemulsions for ultrasound-mediated drug delivery and imaging
KR20230005417A (ko) * 2010-12-17 2023-01-09 셀룰래리티 인코포레이티드 양막 유래 부착성 세포를 사용한, 면역-관련 질환 및 장애의 치료
US20150030619A1 (en) * 2011-09-06 2015-01-29 The Trustees Of Columbia University In The City Of New York Activation and Expansion of T Cell Subsets Using Biocompatible Solid Substrates with Tunable Rigidity
WO2014012082A2 (en) * 2012-07-13 2014-01-16 Zymeworks Inc. Multivalent heteromultimer scaffold design an constructs

Also Published As

Publication number Publication date
EP3013942A1 (en) 2016-05-04
JP2016523102A (ja) 2016-08-08
JP2021106602A (ja) 2021-07-29
WO2014209855A1 (en) 2014-12-31
AU2020210144A1 (en) 2020-08-13
EP3640325A1 (en) 2020-04-22
AU2014302771A1 (en) 2016-01-28
JP2019150049A (ja) 2019-09-12
JP6870026B2 (ja) 2021-05-12
CA2916865A1 (en) 2014-12-31
US20200407681A1 (en) 2020-12-31
EP3013942A4 (en) 2016-11-23
US20160137980A1 (en) 2016-05-19

Similar Documents

Publication Publication Date Title
HK1223553A1 (zh) 細胞
IL244791A0 (en) Methods for modifying a host cell
EP3540243C0 (de) Spreizanker
EP2968549A4 (en) CELL CULTURE METHODS
EP2971014A4 (en) CELL CULTURE METHODS
EP2971040A4 (en) CELL CULTURE METHODS
GB201401248D0 (en) Method of manufacture
EP2946523A4 (en) METHODS AND NODES FOR DETECTING ACTIVATION OF A DESERT CELL
HK1209324A1 (zh) 納米酶、製備納米酶的方法、以及使用納米酶的方法
SG11201601541TA (en) Linked arrays of void cells
HK1201841A1 (zh) 穩定固體形式的瑞加德松
IL245272B (en) pif-transfected cells and methods of use
HK1221260A1 (zh) 擴增 細胞的方法
EP2943982A4 (en) MEMORY CELLS AND METHODS FOR FORMING MEMORY CELLS
GB201310031D0 (en) Cell
EP2982171A4 (en) BACKGROUND SEARCH OF SMALL CELLS
GB201305231D0 (en) Method of Manufacture
HUE046356T2 (hu) Eljárás hematopoietikus õssejtek expandálására
GB201317081D0 (en) Estimation of level-thresholds for memory cells
GB201306810D0 (en) Methods of cell separation
EP3043646A4 (en) Methods of making 2-halonicotinonitriles
GB2517189B (en) Footwear and methods of making footwear
GB201315033D0 (en) Method of cell preservation
TWM475821U (en) Structure of mosquito-catch
TWM475524U (en) Structure of rivet-pulling